Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatments reduce knee osteoarthritis inflammation, with pure PRP being more effective.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Dienogest and combined oral contraceptives are equally effective for endometriosis, but COC may reduce painful intercourse more.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Inclisiran is effective at lowering cholesterol.

Calotropis gigantea and Tridax procumbens extracts reduce inflammation more effectively than low-dose Ibuprofen.

Quadruple-coated probiotics significantly improve IBS symptoms.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Aerobic exercise helps protect the intestines by improving their barrier function.

Nrf-2-modified stem cells from hair follicles significantly improve ulcerative colitis in rats.

The treatment was ineffective in humans.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Levofloxacin and metronidazole reduce inflammation and speed up healing in gingival wounds.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Some dibenzo compounds might help treat cancer with fewer side effects.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.